Core Points - Huabang Health announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has received the drug registration certificates for two specifications of Mometasone Furoate Cream from the National Medical Products Administration [2] Group 1 - The approval of Mometasone Furoate Cream is a significant milestone for the company, enhancing its product portfolio in the pharmaceutical sector [2] - The registration certificates indicate compliance with regulatory standards, which may facilitate market entry and sales growth for the company [2]

Core Viewpoint - Huabang Health has received approval for the registration of Mometasone Furoate Cream from the National Medical Products Administration, which may enhance its product portfolio and revenue potential [1] Company Summary - Huabang Health's subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has obtained two specifications of the drug registration certificate for Mometasone Furoate Cream [1] - As of the latest report, Huabang Health has a market capitalization of 9.3 billion yuan [1] Industry Summary - For the first half of 2025, Huabang Health's revenue composition is as follows: pesticides account for 56.82%, pharmaceuticals for 27.33%, tourism for 8.29%, others for 4.34%, and medical services for 3.21% [1]

Group 1 - The company Huabang Health (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has recently received the drug registration certificate from the National Medical Products Administration for two specifications of Mometasone Furoate Cream [1] - Mometasone Furoate Cream is primarily used for the treatment of eczema, neurodermatitis, atopic dermatitis, and pruritus [1]

格隆汇9月16日丨华邦健康(002004.SZ)公布，公司全资子公司重庆华邦制药有限公司（称"华邦制药"） 于近日收到国家药品监督管理局核准签发的关于糠酸莫米松乳膏的两个规格的《药品注册证书》，糠酸 莫米松乳膏主要用于湿疹、神经性皮炎、异位性皮炎及皮肤瘙痒症。 ...

Core Viewpoint - Huabang Health (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has received the drug registration certificates for two specifications of Mometasone Furoate Cream from the National Medical Products Administration. The cream is primarily used for eczema, neurodermatitis, atopic dermatitis, and pruritus [1] Group 1 - The drug registration certificates were issued for two specifications of Mometasone Furoate Cream [1] - Mometasone Furoate Cream is indicated for the treatment of eczema, neurodermatitis, atopic dermatitis, and skin itching [1]

Core Viewpoint - Huabang Health's subsidiary Huabang Pharmaceutical has received approval from the National Medical Products Administration for the drug registration certificate of Mometasone Furoate Cream in two specifications, indicating a significant regulatory milestone for the company [1] Company Summary - Huabang Pharmaceutical's Mometasone Furoate Cream is primarily used for treating eczema, neurodermatitis, atopic dermatitis, and pruritus [1] - The drug was registered as a Class 3 chemical generic drug, which is considered equivalent to passing the consistency evaluation [1]

Core Viewpoint - The article discusses the results of drug production supervision inspections conducted by the Jiangxi Provincial Drug Supervision Administration from January to June 2025, highlighting compliance and non-compliance among various pharmaceutical companies [2][3][4]. Summary by Category Inspection Results - A total of 23 pharmaceutical companies were inspected during the first half of 2025, with most companies found to be compliant with the Good Manufacturing Practice (GMP) standards [2][3]. - Specific companies such as Jiangxi Ma Kang Pharmaceutical Co., Ltd. and Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd. were noted for their compliance in producing various drug forms including eye drops and traditional Chinese medicine [2][3]. Compliance Details - Companies like Jiangxi Qinfeng Pharmaceutical Co., Ltd. and Jiangxi Yichuan Pharmaceutical Technology Co., Ltd. were recognized for their adherence to GMP during inspections, covering a range of products from small volume injections to tablets [3][4]. - The inspections included checks on production lines for specific drugs, ensuring that companies met the required safety and quality standards [2][3]. Non-Compliance Issues - Some companies faced issues during inspections, although the article primarily focuses on those that complied with regulations [2][3]. - The inspections aimed to ensure that all pharmaceutical products manufactured in the province meet the necessary legal and quality standards [2][3][4].

Group 1 - The article provides a skincare and mosquito prevention guide during the summer season, emphasizing the importance of protecting the skin from sun exposure and insect bites [1] - Traditional methods such as using herbal sachets and planting specific plants like mint and lavender are suggested for natural mosquito repellent [2] - The article highlights the timing of mosquito activity, recommending avoidance of outdoor activities during dawn and dusk, and suggests wearing protective clothing [2] Group 2 - For soothing mosquito bites, the article recommends using herbal remedies like mint and wild chrysanthemum, which can alleviate itching and reduce inflammation [3] - It also mentions the use of topical treatments such as calamine lotion and mild corticosteroids for more severe reactions [3] - The article advises against scratching the affected areas to prevent further irritation [3] Group 3 - The article suggests dietary adjustments to combat summer heat, recommending bitter foods like bitter lettuce and lotus leaf porridge to help regulate body temperature and reduce moisture [4] - It emphasizes the importance of hydration and consuming high-fiber foods to maintain overall health during the summer [4] - The article concludes that a proper diet can help reduce the body's attractiveness to mosquitoes, thereby minimizing bites [4]